Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Pharmacology Study of CS-3150: Drug-drug Interaction with Digoxin or Rifampicin in Healthy Japanese Subjects
jRCT2080223388Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of esaxerenone in hypertension (HTN) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Digoxin Cmax at steady state with and without coadministration of esaxerenone, Esaxerenone Cmax with and without coadministration of rifampicin and 1 more. Started Nov 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080223388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223388.